[go: up one dir, main page]

Wojtczak et al., 2022 - Google Patents

Structural considerations for building synthetic glycoconjugates as inhibitors for Pseudomonas aeruginosa lectins

Wojtczak et al., 2022

View PDF
Document ID
1124329943800556881
Author
Wojtczak K
Byrne J
Publication year
Publication venue
ChemMedChem

External Links

Snippet

Pseudomonas aeruginosa is a pathogenic bacterium, responsible for a large portion of nosocomial infections globally and designated as critical priority by the World Health Organisation. Its characteristic carbohydrate‐binding proteins LecA and LecB, which play a …
Continue reading at chemistry-europe.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (-N=N-), diazo (=N2), azoxy (>N-O-N< or N(=O)-N<), azido (-N3) or diazoamino (-N=N-N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Wojtczak et al. Structural considerations for building synthetic glycoconjugates as inhibitors for Pseudomonas aeruginosa lectins
Deniaud et al. Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands
Hartmann et al. The bacterial lectin FimH, a target for drug discovery–carbohydrate inhibitors of type 1 fimbriae‐mediated bacterial adhesion
Roberts et al. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens
Cecioni et al. Glycomimetics versus multivalent glycoconjugates for the design of high affinity lectin ligands
McCoy et al. Antibiotics that target protein synthesis
Sommer et al. The virulence factor LecB varies in clinical isolates: consequences for ligand binding and drug discovery
Boukerb et al. Antiadhesive properties of glycoclusters against Pseudomonas aeruginosa lung infection
Marchetti et al. “Rules of engagement” of protein–glycoconjugate interactions: a molecular view achievable by using NMR spectroscopy and molecular modeling
Weis et al. Structural basis of lectin-carbohydrate recognition
Laudadio et al. Natural alkaloid berberine activity against Pseudomonas aeruginosa MexXY-mediated aminoglycoside resistance: in silico and in vitro studies
Hauck et al. Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes
Sansone et al. Calixarenes: from biomimetic receptors to multivalent ligands for biomolecular recognition
Berthet et al. High affinity glycodendrimers for the lectin LecB from Pseudomonas aeruginosa
Goyard et al. Multivalent glycomimetics with affinity and selectivity toward fucose-binding receptors from emerging pathogens
Lei et al. Potentiation of vancomycin: Creating cooperative membrane lysis through a “derivatization-for-sensitization” approach
Miller et al. Structural features for α-galactomannan binding to galectin-1
Francesconi et al. Antiviral activity of synthetic aminopyrrolic carbohydrate binding agents: Targeting the glycans of viral gp120 to inhibit HIV entry
Kuhaudomlarp et al. Non‐carbohydrate glycomimetics as inhibitors of calcium (II)‐binding lectins
Pera et al. Towards bacterial adhesion-based therapeutics and detection methods
Baudendistel et al. Real‐time NMR studies of oxyamine ligations of reducing carbohydrates under equilibrium conditions
Chambers et al. Synthetic ellagic acid glycosides inhibit early stage adhesion of Streptococcus agalactiae biofilms as observed by scanning electron microscopy
Özen et al. Thermodynamics of aminoglycoside binding to aminoglycoside-3 ‘-phosphotransferase IIIa studied by isothermal titration calorimetry
Assailly et al. Polyvalent Transition‐State Analogues of Sialyl Substrates Strongly Inhibit Bacterial Sialidases
Deschner et al. Nitroxoline resistance is associated with significant fitness loss and diminishes in vivo virulence of Escherichia coli